Central Texas Veterans Health Care System
Temple, Texas, 76504, United States
NCT Number: NCT00011583
Our long term objectives are to understand the mechanisms of motor impairment following neurologic injury and to develop interventions to improve motor recovery. A series of complementary, overlapping clinical trials and development activities will validate and optimize the use of robot-assisted upper limb therapy for neuro rehabilitation.
We have developed a robotic system that assists or resists elbow and shoulder movements in three dimensional space. In addition to unilateral exercise modes, a novel bimanual mode enables hemiparetic subjects to practice mirror image upper limb exercises.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Temple, Texas, 76504, United States
Randomized controlled clinical trial of the Mirror Image Movement Enabler (MIME) robotic device for shoulder and elbow neurorehabilitation in subacute stroke patients. MIME incorporates a PUMA 560 robot that applies forces to the paretic limb during unilateral and bilateral movements in three dimensions. Robot-assisted treatment (bilateral, unilateral, and combined bilateral and unilateral) was compared with conventional therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Stroke patients
Exclusion criteria
Unable to follow instructions; medically unstable.
1 hour/day of mechanically-assisted upper limb therapy
1 hour/day of upper limb therapy that includes exposure to, but no manipulation by the robot
Time frame: end of training, 6-month follow-up
US Department of Veterans Affairs
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02368145
Acute Stroke, Brain Diseases
New Brunswick, New Jersey, United States
View Trial DetailsNCT07295366
Acute Stroke, Arterial Occlusive Diseases
Xuzhou, Jiangsu, China
View Trial DetailsNCT02900833
Acute Stroke, Brain Diseases
Paris, France
View Trial DetailsNCT05998902
Acute Stroke, Brain Diseases
Chongqing, Chongqing Municipality, China
View Trial Details